The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Insulin Market Research Report 2025
Synopsis
The oral delivery of drugs is considered as the most acceptable and convenient route of drug administration especially for chronic diseased conditions like diabetes. The treatment with oral insulin offers several advantages, such as higher patient compliance; rapid hepatic insulinization, and avoidance of peripheral hyperinsulinemia and other adverse effects such as possible hypoglycemia and weight gain.
The global Oral Insulin market was valued at US$ 536 million in 2023 and is anticipated to reach US$ 782.1 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Insulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Insulin.
Report Scope
The Oral Insulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Insulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Insulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Oramed Pharmaceuticals
vTv Therapeutics
Diabetology
Generex Biotechnology
Coromed
Nektar Therapeutics
Segment by Type
Type 1 Diabetes
Type 2 Diabetes
Segment by Application
Female
Male
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Insulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Insulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The oral delivery of drugs is considered as the most acceptable and convenient route of drug administration especially for chronic diseased conditions like diabetes. The treatment with oral insulin offers several advantages, such as higher patient compliance; rapid hepatic insulinization, and avoidance of peripheral hyperinsulinemia and other adverse effects such as possible hypoglycemia and weight gain.
The global Oral Insulin market was valued at US$ 536 million in 2023 and is anticipated to reach US$ 782.1 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Insulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Insulin.
Report Scope
The Oral Insulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Insulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Insulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Oramed Pharmaceuticals
vTv Therapeutics
Diabetology
Generex Biotechnology
Coromed
Nektar Therapeutics
Segment by Type
Type 1 Diabetes
Type 2 Diabetes
Segment by Application
Female
Male
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Insulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Insulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oral Insulin Market Overview
1.1 Product Overview and Scope of Oral Insulin
1.2 Oral Insulin Segment by Type
1.2.1 Global Oral Insulin Market Value Comparison by Type (2024-2030)
1.2.2 Type 1 Diabetes
1.2.3 Type 2 Diabetes
1.3 Oral Insulin Segment by Application
1.3.1 Global Oral Insulin Market Value by Application: (2024-2030)
1.3.2 Female
1.3.3 Male
1.4 Global Oral Insulin Market Size Estimates and Forecasts
1.4.1 Global Oral Insulin Revenue 2019-2030
1.4.2 Global Oral Insulin Sales 2019-2030
1.4.3 Global Oral Insulin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Insulin Market Competition by Manufacturers
2.1 Global Oral Insulin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Insulin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Insulin Average Price by Manufacturers (2019-2024)
2.4 Global Oral Insulin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Insulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Insulin, Product Type & Application
2.7 Oral Insulin Market Competitive Situation and Trends
2.7.1 Oral Insulin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Insulin Players Market Share by Revenue
2.7.3 Global Oral Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Insulin Retrospective Market Scenario by Region
3.1 Global Oral Insulin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Insulin Global Oral Insulin Sales by Region: 2019-2030
3.2.1 Global Oral Insulin Sales by Region: 2019-2024
3.2.2 Global Oral Insulin Sales by Region: 2025-2030
3.3 Global Oral Insulin Global Oral Insulin Revenue by Region: 2019-2030
3.3.1 Global Oral Insulin Revenue by Region: 2019-2024
3.3.2 Global Oral Insulin Revenue by Region: 2025-2030
3.4 North America Oral Insulin Market Facts & Figures by Country
3.4.1 North America Oral Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Insulin Sales by Country (2019-2030)
3.4.3 North America Oral Insulin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Insulin Market Facts & Figures by Country
3.5.1 Europe Oral Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Insulin Sales by Country (2019-2030)
3.5.3 Europe Oral Insulin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Insulin Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Insulin Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Insulin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Insulin Market Facts & Figures by Country
3.7.1 Latin America Oral Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Insulin Sales by Country (2019-2030)
3.7.3 Latin America Oral Insulin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Insulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Insulin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Insulin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oral Insulin Sales by Type (2019-2030)
4.1.1 Global Oral Insulin Sales by Type (2019-2024)
4.1.2 Global Oral Insulin Sales by Type (2025-2030)
4.1.3 Global Oral Insulin Sales Market Share by Type (2019-2030)
4.2 Global Oral Insulin Revenue by Type (2019-2030)
4.2.1 Global Oral Insulin Revenue by Type (2019-2024)
4.2.2 Global Oral Insulin Revenue by Type (2025-2030)
4.2.3 Global Oral Insulin Revenue Market Share by Type (2019-2030)
4.3 Global Oral Insulin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Insulin Sales by Application (2019-2030)
5.1.1 Global Oral Insulin Sales by Application (2019-2024)
5.1.2 Global Oral Insulin Sales by Application (2025-2030)
5.1.3 Global Oral Insulin Sales Market Share by Application (2019-2030)
5.2 Global Oral Insulin Revenue by Application (2019-2030)
5.2.1 Global Oral Insulin Revenue by Application (2019-2024)
5.2.2 Global Oral Insulin Revenue by Application (2025-2030)
5.2.3 Global Oral Insulin Revenue Market Share by Application (2019-2030)
5.3 Global Oral Insulin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Oral Insulin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Oral Insulin Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Oramed Pharmaceuticals
6.2.1 Oramed Pharmaceuticals Corporation Information
6.2.2 Oramed Pharmaceuticals Description and Business Overview
6.2.3 Oramed Pharmaceuticals Oral Insulin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Oramed Pharmaceuticals Oral Insulin Product Portfolio
6.2.5 Oramed Pharmaceuticals Recent Developments/Updates
6.3 vTv Therapeutics
6.3.1 vTv Therapeutics Corporation Information
6.3.2 vTv Therapeutics Description and Business Overview
6.3.3 vTv Therapeutics Oral Insulin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 vTv Therapeutics Oral Insulin Product Portfolio
6.3.5 vTv Therapeutics Recent Developments/Updates
6.4 Diabetology
6.4.1 Diabetology Corporation Information
6.4.2 Diabetology Description and Business Overview
6.4.3 Diabetology Oral Insulin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Diabetology Oral Insulin Product Portfolio
6.4.5 Diabetology Recent Developments/Updates
6.5 Generex Biotechnology
6.5.1 Generex Biotechnology Corporation Information
6.5.2 Generex Biotechnology Description and Business Overview
6.5.3 Generex Biotechnology Oral Insulin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Generex Biotechnology Oral Insulin Product Portfolio
6.5.5 Generex Biotechnology Recent Developments/Updates
6.6 Coromed
6.6.1 Coromed Corporation Information
6.6.2 Coromed Description and Business Overview
6.6.3 Coromed Oral Insulin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Coromed Oral Insulin Product Portfolio
6.6.5 Coromed Recent Developments/Updates
6.7 Nektar Therapeutics
6.6.1 Nektar Therapeutics Corporation Information
6.6.2 Nektar Therapeutics Description and Business Overview
6.6.3 Nektar Therapeutics Oral Insulin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nektar Therapeutics Oral Insulin Product Portfolio
6.7.5 Nektar Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Insulin Industry Chain Analysis
7.2 Oral Insulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Insulin Production Mode & Process
7.4 Oral Insulin Sales and Marketing
7.4.1 Oral Insulin Sales Channels
7.4.2 Oral Insulin Distributors
7.5 Oral Insulin Customers
8 Oral Insulin Market Dynamics
8.1 Oral Insulin Industry Trends
8.2 Oral Insulin Market Drivers
8.3 Oral Insulin Market Challenges
8.4 Oral Insulin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Oral Insulin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Oral Insulin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Oral Insulin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Oral Insulin Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Oral Insulin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Oral Insulin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Oral Insulin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Oral Insulin Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Oral Insulin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Insulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Insulin, Product Type & Application
Table 12. Global Key Manufacturers of Oral Insulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Insulin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Insulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Oral Insulin Sales by Region (2019-2024) & (K Units)
Table 18. Global Oral Insulin Sales Market Share by Region (2019-2024)
Table 19. Global Oral Insulin Sales by Region (2025-2030) & (K Units)
Table 20. Global Oral Insulin Sales Market Share by Region (2025-2030)
Table 21. Global Oral Insulin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Oral Insulin Revenue Market Share by Region (2019-2024)
Table 23. Global Oral Insulin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Oral Insulin Revenue Market Share by Region (2025-2030)
Table 25. North America Oral Insulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Oral Insulin Sales by Country (2019-2024) & (K Units)
Table 27. North America Oral Insulin Sales by Country (2025-2030) & (K Units)
Table 28. North America Oral Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Oral Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Oral Insulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Oral Insulin Sales by Country (2019-2024) & (K Units)
Table 32. Europe Oral Insulin Sales by Country (2025-2030) & (K Units)
Table 33. Europe Oral Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Oral Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Oral Insulin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Oral Insulin Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Oral Insulin Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Oral Insulin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Oral Insulin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oral Insulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Oral Insulin Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Oral Insulin Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Oral Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oral Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Oral Insulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Oral Insulin Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Oral Insulin Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Oral Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Oral Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Oral Insulin Sales (K Units) by Type (2019-2024)
Table 51. Global Oral Insulin Sales (K Units) by Type (2025-2030)
Table 52. Global Oral Insulin Sales Market Share by Type (2019-2024)
Table 53. Global Oral Insulin Sales Market Share by Type (2025-2030)
Table 54. Global Oral Insulin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Oral Insulin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Oral Insulin Revenue Market Share by Type (2019-2024)
Table 57. Global Oral Insulin Revenue Market Share by Type (2025-2030)
Table 58. Global Oral Insulin Price (US$/Unit) by Type (2019-2024)
Table 59. Global Oral Insulin Price (US$/Unit) by Type (2025-2030)
Table 60. Global Oral Insulin Sales (K Units) by Application (2019-2024)
Table 61. Global Oral Insulin Sales (K Units) by Application (2025-2030)
Table 62. Global Oral Insulin Sales Market Share by Application (2019-2024)
Table 63. Global Oral Insulin Sales Market Share by Application (2025-2030)
Table 64. Global Oral Insulin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Oral Insulin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Oral Insulin Revenue Market Share by Application (2019-2024)
Table 67. Global Oral Insulin Revenue Market Share by Application (2025-2030)
Table 68. Global Oral Insulin Price (US$/Unit) by Application (2019-2024)
Table 69. Global Oral Insulin Price (US$/Unit) by Application (2025-2030)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Novo Nordisk Oral Insulin Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Oramed Pharmaceuticals Corporation Information
Table 76. Oramed Pharmaceuticals Description and Business Overview
Table 77. Oramed Pharmaceuticals Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Oramed Pharmaceuticals Oral Insulin Product
Table 79. Oramed Pharmaceuticals Recent Developments/Updates
Table 80. vTv Therapeutics Corporation Information
Table 81. vTv Therapeutics Description and Business Overview
Table 82. vTv Therapeutics Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. vTv Therapeutics Oral Insulin Product
Table 84. vTv Therapeutics Recent Developments/Updates
Table 85. Diabetology Corporation Information
Table 86. Diabetology Description and Business Overview
Table 87. Diabetology Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Diabetology Oral Insulin Product
Table 89. Diabetology Recent Developments/Updates
Table 90. Generex Biotechnology Corporation Information
Table 91. Generex Biotechnology Description and Business Overview
Table 92. Generex Biotechnology Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Generex Biotechnology Oral Insulin Product
Table 94. Generex Biotechnology Recent Developments/Updates
Table 95. Coromed Corporation Information
Table 96. Coromed Description and Business Overview
Table 97. Coromed Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Coromed Oral Insulin Product
Table 99. Coromed Recent Developments/Updates
Table 100. Nektar Therapeutics Corporation Information
Table 101. Nektar Therapeutics Description and Business Overview
Table 102. Nektar Therapeutics Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Nektar Therapeutics Oral Insulin Product
Table 104. Nektar Therapeutics Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Oral Insulin Distributors List
Table 108. Oral Insulin Customers List
Table 109. Oral Insulin Market Trends
Table 110. Oral Insulin Market Drivers
Table 111. Oral Insulin Market Challenges
Table 112. Oral Insulin Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Insulin
Figure 2. Global Oral Insulin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Oral Insulin Market Share by Type in 2023 & 2030
Figure 4. Type 1 Diabetes Product Picture
Figure 5. Type 2 Diabetes Product Picture
Figure 6. Global Oral Insulin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Oral Insulin Market Share by Application in 2023 & 2030
Figure 8. Female
Figure 9. Male
Figure 10. Global Oral Insulin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Oral Insulin Market Size (2019-2030) & (US$ Million)
Figure 12. Global Oral Insulin Sales (2019-2030) & (K Units)
Figure 13. Global Oral Insulin Average Price (US$/Unit) & (2019-2030)
Figure 14. Oral Insulin Report Years Considered
Figure 15. Oral Insulin Sales Share by Manufacturers in 2023
Figure 16. Global Oral Insulin Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Oral Insulin Players: Market Share by Revenue in 2023
Figure 18. Oral Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Oral Insulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Oral Insulin Sales Market Share by Country (2019-2030)
Figure 21. North America Oral Insulin Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Oral Insulin Sales Market Share by Country (2019-2030)
Figure 25. Europe Oral Insulin Revenue Market Share by Country (2019-2030)
Figure 26. Germany Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Oral Insulin Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Oral Insulin Revenue Market Share by Region (2019-2030)
Figure 33. China Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Oral Insulin Sales Market Share by Country (2019-2030)
Figure 44. Latin America Oral Insulin Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Oral Insulin Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Oral Insulin Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Oral Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Oral Insulin by Type (2019-2030)
Figure 54. Global Revenue Market Share of Oral Insulin by Type (2019-2030)
Figure 55. Global Oral Insulin Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Oral Insulin by Application (2019-2030)
Figure 57. Global Revenue Market Share of Oral Insulin by Application (2019-2030)
Figure 58. Global Oral Insulin Price (US$/Unit) by Application (2019-2030)
Figure 59. Oral Insulin Value Chain
Figure 60. Oral Insulin Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
